1 Carlsson, S. Etiology and Pathogenesis of Latent Autoimmune Diabetes in Adults (LADA) Compared to Type 2 Diabetes. Frontiers in Physiology 10, 320 (2019).
2 Regnell, S. E. & Lernmark, Å. Early prediction of autoimmune (type 1) diabetes. Diabetologia 60, 1370-1381, doi:10.1007/s00125-017-4308-1 (2017).
3 Maddaloni, E., Moretti, C., Mignogna, C. & Buzzetti, R. Adult-onset autoimmune diabetes in 2020: An update. Maturitas 137, 37-44, doi:10.1016/j.maturitas.2020.04.014 (2020).
4 Buzzetti, R. et al. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. Diabetes 69, 2037, doi:10.2337/dbi20-0017 (2020).
5 Hawa, M. I. et al. Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype. Diabetes Care 36, 908, doi:10.2337/dc12-0931 (2013).
6 Fadiga, L. et al. Adult-onset autoimmune diabetes: comparative analysis of classical and latent presentation. Diabetology & Metabolic Syndrome 12, 107, doi:10.1186/s13098-020-00616-1 (2020).
7 Xiang, Y. et al. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5. Acta Diabetologica 52, 1121-1127, doi:10.1007/s00592-015-0799-8 (2015).
8 Hawa, M. I. et al. LADA and CARDS: A Prospective Study of Clinical Outcome in Established Adult-Onset Autoimmune Diabetes. Diabetes Care 37, 1643, doi:10.2337/dc13-2383 (2014).
9 Maddaloni, E., Coleman, R. L., Agbaje, O., Buzzetti, R. & Holman, R. R. Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86). The Lancet Diabetes & Endocrinology 8, 206-215, doi:10.1016/S2213-8587(20)30003-6 (2020).
10 Brahmkshatriya, P. P., Mehta, A. A., Saboo, B. D. & Goyal, R. K. Characteristics and Prevalence of Latent Autoimmune Diabetes in Adults (LADA). ISRN Pharmacol 2012, 580202-580202, doi:10.5402/2012/580202 (2012).
11 Hjort, R. et al. Overweight, obesity and the risk of LADA: results from a Swedish case–control study and the Norwegian HUNT Study. Diabetologia 61, 1333-1343, doi:10.1007/s00125-018-4596-0 (2018).
12 Herzog, K. et al. Combined lifestyle factors and the risk of LADA and type 2 diabetes – Results from a Swedish population-based case-control study. Diabetes Research and Clinical Practice 174, doi:10.1016/j.diabres.2021.108760 (2021).
13 Nyström, T., Holzmann, M. J., Eliasson, B., Svensson, A.-M. & Sartipy, U. Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes. Diabetes, Obesity and Metabolism 20, 556-563, doi:https://doi.org/10.1111/dom.13110 (2018).
14 Williams, K. V., Erbey, J. R., Becker, D., Arslanian, S. & Orchard, T. J. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49, 626-632, doi:10.2337/diabetes.49.4.626 (2000).
15 Alberti, K. G. & Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539-553, doi:10.1002/(sici)1096-9136(199807)15:7<539::Aid-dia668>3.0.Co;2-s (1998).
16 Mishra, R. et al. Genetic Discrimination Between LADA and Childhood-Onset Type 1 Diabetes Within the MHC. Diabetes Care 43, 418-425, doi:10.2337/dc19-0986 (2019).
17 Huang, G. et al. Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up. Diabetes/Metabolism Research and Reviews 32, 615-622, doi:https://doi.org/10.1002/dmrr.2779 (2016).
18 Zampetti, S. et al. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7). European Journal of Endocrinology 171, 697-704, doi:10.1530/EJE-14-0342 (2014).
19 Hjort, R. et al. Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA). Diabetes & Metabolism 43, 536-542, doi:https://doi.org/10.1016/j.diabet.2017.05.010 (2017).
20 Adeleye, O. O. et al. Latent Autoimmune Diabetes Mellitus in Adults (LADA) and it's characteristics in a subset of Nigerians initially managed for type 2 diabetes. Int Arch Med 5, 23-23, doi:10.1186/1755-7682-5-23 (2012).
21 Tam, A. A. et al. Low rate of latent autoimmune diabetes in adults (LADA) in patients followed for type 2 diabetes: A single center's experience in Turkey. Arch Endocrinol Metab 64, 584-590, doi:10.20945/2359-3997000000268 (2021).
22 Hernández, M. et al. Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes. Cardiovascular Diabetology 16, 94, doi:10.1186/s12933-017-0576-9 (2017).
23 Cardoso-Sánchez, L. I., Gómez-Díaz, R. A. & Wacher, N. H. Vitamin D intake associates with insulin resistance in type 2 diabetes, but not in latent autoimmune diabetes in adults. Nutrition Research 35, 689-699, doi:https://doi.org/10.1016/j.nutres.2015.05.019 (2015).
24 Grill, V. LADA: A Type of Diabetes in its Own Right? Current Diabetes Reviews 15, 174-177, doi:http://dx.doi.org/10.2174/1573399814666180716150905 (2019).
25 Zinman, B. et al. Phenotypic Characteristics of GAD Antibody-Positive Recently Diagnosed Patients With Type 2 Diabetes in North America and Europe. Diabetes 53, 3193-3200, doi:10.2337/diabetes.53.12.3193 (2004).
26 Zabala, A. et al. Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study. Cardiovascular Diabetology 20, 202, doi:10.1186/s12933-021-01394-4 (2021).
27 Teixeira, M. M. et al. Insulin resistance and associated factors in patients with Type 1 Diabetes. Diabetology & Metabolic Syndrome 6, 131, doi:10.1186/1758-5996-6-131 (2014).
28 Helmink, M. A. G. et al. Insulin resistance and risk of vascular events, interventions and mortality in type 1 diabetes. European Journal of Endocrinology 185, 831-840, doi:10.1530/EJE-21-0636 (2021).
29 Siewko, K. et al. Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development. Biomed Res Int 2019, 4734063, doi:10.1155/2019/4734063 (2019).
30 Epstein, E. J. et al. Use of the Estimated Glucose Disposal Rate as a Measure of Insulin Resistance in an Urban Multiethnic Population With Type 1 Diabetes. Diabetes Care 36, 2280-2285, doi:10.2337/dc12-1693 (2013).
31 Pozzilli, P. & Pieralice, S. Latent Autoimmune Diabetes in Adults: Current Status and New Horizons. Endocrinol Metab 33, 147-159, doi:10.3803/EnM.2018.33.2.147 (2018).